excellent pre-clinical efficacy in Myc-dependent tumor models and are currently in clinical trials. Several groups have also reported small molecule inhibitors that bind directly to Myc and inhibit its interaction…
EZH2 through the use of a low-homology vSET structure that also binds H3K27. This suggests that the design of such histone-modifying enzymes may not need an exact experimental structure, but…
our combined treatment with bortezomib and mitotic inhibitors is able to target Bcr-Abl with T315I mutation. Moreover, lower concentrations of each drug can be used in synergistic combinations, which may…
the protein tyrosine kinases tested is appreciably affected by TBID with the only possible exception of IGF-IR. This together with CAMK1 and CAMKKb are the only kinases inhibited more than…
3-uptake into differentiating osteoclasts, whereas no C3-specific staining was detected in untreated control cells. The images of C2IN-C3lim-treated L67 osteoclasts show the distribution of internalized C2IN-C3lim in the cells. The…